Cancer chemoprevention volume 2: strategies for cancer chemoprevention /

由 Kelloff, Gary J., Hawk, Ernest T., Sigman, Caroline C.
出版 c200

Biomarker Development in the Context of Urologic Cancers

由 Kelloff, Gary J., Sigman, Caroline C., Scher, Howard I.
發表在 Urol Oncol (2015)

Lessons Learned: Transfer of the High Definition-Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform

由 Kuhn, Peter, Keating, Susan M., Baxter, Gregory T., Thomas, Kisha, Kolatkar, Anand, Sigman, Caroline C.
發表在 Clin Pharmacol Ther (2017)

Chemoprevention Strategies in the Prostate: An Overview

由 Kelloff, Gary J, Higley, Howard R, Brawer, Michael K, Lucia, M Scott, Sigman, Caroline C, Crawford, E David
出版 2002

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

由 Taube, Sheila E., Clark, Gary M., Dancey, Janet E., McShane, Lisa M., Sigman, Caroline C., Gutman, Steven I.
出版 2009

Regulatory Approval of Cancer Risk-reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic

由 Meyskens, Frank L., Curt, Gregory A., Brenner, Dean E., Gordon, Gary, Herberman, Ronald B., Finn, Olivera, Kelloff, Gary J., Khleif, Samir N., Sigman, Caroline C., Szabo, Eva
出版 2011

Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical Translation

由 Keating, Susan M., Taylor, D. Lansing, Plant, Anne L., Litwack, E. David, Kuhn, Peter, Greenspan, Emily J., Hartshorn, Christopher M., Sigman, Caroline C., Kelloff, Gary J., Chang, David D., Friberg, Gregory, Lee, Jerry S. H., Kuida, Keisuke
發表在 Clin Transl Sci (2018)

A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters

由 Keeney, Michael, Wood, Brent L., Hedley, Benjamin D., DiGiuseppe, Joseph A., Stetler-Stevenson, Maryalice, Paietta, Elisabeth, Lozanski, Gerard, Seegmiller, Adam C., Greig, Bruce W., Shaver, Aaron C., Mukundan, Lata, Higley, Howard R., Sigman, Caroline C., Kelloff, Gary, Jessup, J. Milburn, Borowitz, Michael J.
發表在 Cytometry B Clin Cytom (2017)

Considerations in the development of circulating tumor cell technology for clinical use

由 Parkinson, David R, Dracopoli, Nicholas, Petty, Brenda Gumbs, Compton, Carolyn, Cristofanilli, Massimo, Deisseroth, Albert, Hayes, Daniel F, Kapke, Gordon, Kumar, Prasanna, Lee, Jerry SH, Liu, Minetta C, McCormack, Robert, Mikulski, Stanislaw, Nagahara, Larry, Pantel, Klaus, Pearson-White, Sonia, Punnoose, Elizabeth A, Roadcap, Lori T, Schade, Andrew E, Scher, Howard I, Sigman, Caroline C, Kelloff, Gary J
出版 2012

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

由 Herbst, Roy S., Gandara, David R., Hirsch, Fred R., Redman, Mary W., LeBlanc, Michael, Mack, Philip C., Schwartz, Lawrence H., Vokes, Everett, Ramalingam, Suresh S., Bradley, Jeffrey D., Sparks, Dana, Zhou, Yang, Miwa, Crystal, Miller, Vincent A., Yelensky, Roman, Li, Yali, Allen, Jeff D., Sigal, Ellen V., Wholley, David, Sigman, Caroline C., Blumenthal, Gideon M., Malik, Shakun, Kelloff, Gary J., Abrams, Jeffrey S., Blanke, Charles D., Papadimitrakopoulou, Vassiliki A.
發表在 Clin Cancer Res (2015)